(Q38778020)

6 September 2017

title

Immunoglobulin A: magic bullet or Trojan horse? (English)

1 reference

6 September 2017

2

Marjolein van Egmond

0 references

author name string

Marieke H Heineke

series ordinal

1

1 reference

6 September 2017

publication date

26 December 2016

1 reference

European Journal of Clinical Investigation

6 September 2017

published in

1 reference

6 September 2017

volume

47

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

184-192

1 reference

Diverse novel functions of neutrophils in immunity, inflammation, and beyond

6 September 2017

cites work

1 reference

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

Neutrophils in the activation and regulation of innate and adaptive immunity

21 January 2018

1 reference

The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease

21 January 2018

1 reference

Homeland security: IgA immunity at the frontiers of the body

21 January 2018

1 reference

IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fcα receptor I.

21 January 2018

1 reference

Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.

21 January 2018

1 reference

Structure and function relationships in IgA.

21 January 2018

1 reference

The function of immunoglobulin A in immunity

21 January 2018

1 reference

Role of secretory IgA in infection and maintenance of homeostasis

21 January 2018

1 reference

Secretory IgA in the Coordination of Establishment and Maintenance of the Microbiota

21 January 2018

1 reference

The unexplored roles of human serum IgA.

21 January 2018

1 reference

Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.

21 January 2018

1 reference

Inhibitory ITAMs as novel regulators of immunity.

21 January 2018

1 reference

FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity

21 January 2018

1 reference

The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity

21 January 2018

1 reference

Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B.

21 January 2018

1 reference

The gastrointestinal frontier: IgA and viruses

21 January 2018

1 reference

Functional expression of IgA receptor FcalphaRI on human platelets

21 January 2018

1 reference

Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc

21 January 2018

1 reference

Pentraxins and IgA share a binding hot-spot on FcαRI.

21 January 2018

1 reference

Fc receptor inside-out signaling and possible impact on antibody therapy.

21 January 2018

1 reference

Functional Association between the Human Myeloid Immunoglobulin A Fc Receptor (CD89) and FcR [IMAGE] Chain

21 January 2018

1 reference

Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.

21 January 2018

1 reference

IgA deficiency and autoimmunity

21 January 2018

1 reference

Molecular diagnosis in autoimmune skin blistering conditions

21 January 2018

1 reference

Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis

21 January 2018

1 reference

The diagnosis and treatment of dermatitis herpetiformis

21 January 2018

1 reference

Immunoglobulin A nephropathy: current progress and future directions

21 January 2018

1 reference

Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice

21 January 2018

1 reference

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.

21 January 2018

1 reference

IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects

21 January 2018

1 reference

Myeloid cells as effector cells for monoclonal antibody therapy of cancer.

21 January 2018

1 reference

Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy

21 January 2018

1 reference

Neutrophils as effector cells for antibody-based immunotherapy of cancer

21 January 2018

1 reference

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab

21 January 2018

1 reference

Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth

21 January 2018

1 reference

Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis

21 January 2018

1 reference

Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

21 January 2018

1 reference

Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors

21 January 2018

1 reference

IgA antibodies for cancer therapy

21 January 2018

1 reference

Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells

21 January 2018

1 reference

IgA EGFR antibodies mediate tumour killing in vivo

21 January 2018

1 reference

An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo.

21 January 2018

1 reference

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

21 January 2018

1 reference

Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

21 January 2018

1 reference

IgGA: a "cross-isotype" engineered human Fc antibody domain that displays both IgG-like and IgA-like effector functions.

21 January 2018

1 reference

Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding

21 January 2018

1 reference

Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway

21 January 2018

1 reference

Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation

21 January 2018

1 reference

Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.

21 January 2018

1 reference

The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.

21 January 2018

1 reference

Expression cloning of a human Fc receptor for IgA

21 January 2018

1 reference

Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy

21 January 2018

1 reference

IgA interaction with the asialoglycoprotein receptor

21 January 2018

1 reference

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes

21 January 2018

1 reference

Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

21 January 2018

1 reference

Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice.

21 January 2018

1 reference

Transepithelial transport of immunoglobulins

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12716

1 reference

6 September 2017

1 reference